Author:
Gauna Fatima,Verger Pierre,Fressard Lisa,Jardin Marie,Ward Jeremy K.,Peretti-Watel Patrick
Abstract
BackgroundThe human papillomavirus (HPV) vaccine reduces the burden of cervical and other cancers. In numerous countries, a slow uptakeof this vaccine persists, calling for a better understanding of the structural factors leading to vaccine acceptation. We aimed to assess the attitudes toward HPV vaccination among its intended public to explore its specific characteristics.MethodsA random cross-sectional telephone survey of the French general population provided data from a sample of 2426 respondents of the target public: the parents of young women and the young women aged 15-25 themselves. We applied cluster analysis to identify contrasting attitudinal profiles, and logistic regressions with a model averaging method to investigate and rank the factors associated with these profiles.ResultsA third of the respondents had never heard of HPV. However, most of the respondents who had heard of it agreed that it is a severe (93.8%) and frequent (65.1%) infection. Overall, 72.3% of them considered the HPV vaccine to be effective, but 54% had concerns about its side effects. We identified four contrasting profiles based on their perceptions of this vaccine: informed supporters, objectors, uninformed supporters, and those who were uncertain. In multivariate analysis, these attitudinal clusters were the strongest predictors of HPV vaccine uptake, followed by attitudes toward vaccination in general.ConclusionsTailored information campaigns and programs should address the specific and contrasted concerns about HPV vaccination of both young women and of their parents.
Funder
Institut pour la Recherche en Santé Publique
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference51 articles.
1. Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:14–26.
2. de Sanjosé S, Brotons M, Pavón MA. The natural history of human papillomavirus infection . 2018. Available from: https://doi.org/10.1016/j.bpobgyn.2017.08.015.
3. Abramowitz L, Lacau Saint Guily J, Moyal-Barracco M, Bergeron C, Borne H, Dahlab A, et al. Epidemiological and economic bur- den of potentially HPV-related cancers in France. PLOS ONE. 2018;13(9):e0202564. https://doi.org/10.1371/journal.pone.0202564.
4. Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M. Human papillomavirus-attributable cancers—United States, 2012–2016. Morb Mortal Wkly Rep. 2019;68(33):724.
5. World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017. Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire. 2017;92(19):241–68.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献